10-Q/A XBRL

AMENDMENT FOR XBRL

Company: PharmaCyte Biotech, Inc.
Filed: March 13, 2017
Period of Report: January 31, 2017
Accession Number: 0001683168-17-000544

View Document ↗ View on SEC.gov ↗